Annual Current Assets
$256.13 M
+$30.76 M+13.65%
December 31, 2023
Summary
- As of February 12, 2025, TARS annual total current assets is $256.13 million, with the most recent change of +$30.76 million (+13.65%) on December 31, 2023.
- During the last 3 years, TARS annual current assets has risen by +$85.48 million (+50.09%).
- TARS annual current assets is now at all-time high.
Performance
TARS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$357.12 M
-$5.47 M-1.51%
September 30, 2024
Summary
- As of February 12, 2025, TARS quarterly total current assets is $357.12 million, with the most recent change of -$5.47 million (-1.51%) on September 30, 2024.
- Over the past year, TARS quarterly current assets has increased by +$100.99 million (+39.43%).
- TARS quarterly current assets is now -1.51% below its all-time high of $362.59 million, reached on June 30, 2024.
Performance
TARS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TARS Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.7% | +39.4% |
| 3 y3 years | +50.1% | +39.4% |
| 5 y5 years | +10000.0% | +39.4% |
TARS Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.6% | -1.5% | +103.0% |
| 5 y | 5-year | at high | +341.4% | -1.5% | +552.8% |
| alltime | all time | at high | >+9999.0% | -1.5% | +552.8% |
Tarsus Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $357.12 M(-1.5%) |
| Jun 2024 | - | $362.59 M(+6.4%) |
| Mar 2024 | - | $340.72 M(+33.0%) |
| Dec 2023 | $9.36 M(+276.2%) | $256.13 M(-1.2%) |
| Sep 2023 | - | $259.28 M(+41.3%) |
| Jun 2023 | - | $183.48 M(-12.1%) |
| Mar 2023 | - | $208.65 M(-7.4%) |
| Dec 2022 | $2.49 M | $225.38 M(-3.7%) |
| Sep 2022 | - | $234.08 M(-6.5%) |
| Jun 2022 | - | $250.28 M(+40.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $178.75 M(+1.6%) |
| Dec 2021 | $2.96 M(+124.4%) | $175.95 M(-6.0%) |
| Sep 2021 | - | $187.09 M(-6.9%) |
| Jun 2021 | - | $200.90 M(+4.9%) |
| Mar 2021 | - | $191.45 M(+12.2%) |
| Dec 2020 | $1.32 M(+360.5%) | $170.66 M(+91.6%) |
| Sep 2020 | - | $89.07 M(+62.8%) |
| Jun 2020 | - | $54.71 M(-5.7%) |
| Dec 2019 | $286.00 K(+4666.7%) | $58.03 M |
| Dec 2018 | $6000.00 | - |
FAQ
- What is Tarsus Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual current assets year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly current assets year-on-year change?
What is Tarsus Pharmaceuticals annual total current assets?
The current annual current assets of TARS is $256.13 M
What is the all time high annual current assets for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total current assets is $256.13 M
What is Tarsus Pharmaceuticals annual current assets year-on-year change?
Over the past year, TARS annual total current assets has changed by +$30.76 M (+13.65%)
What is Tarsus Pharmaceuticals quarterly total current assets?
The current quarterly current assets of TARS is $357.12 M
What is the all time high quarterly current assets for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total current assets is $362.59 M
What is Tarsus Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, TARS quarterly total current assets has changed by +$100.99 M (+39.43%)